| Literature DB >> 35602316 |
Mahsa Ghasemi1, Deblina Roy2, Mina Shabani1, Nitika Singh2, Reza Pirzeh1, Sujita Kumar Kar2.
Abstract
An emergence of mental health issues among the general population has been reported during the COVID-19 pandemic. This study aimed to estimate COVID-19 awareness, attitude, and perceived anxiety among the Iranian people. This is a cross-sectional web-based survey done on the community population of Iran. The sample population was recruited through purposive sampling. The study questionnaire was circulated through online platforms as a web link. A questionnaire used in previous research has been used after translation in a sample of 375 adults from Iran. The majority of the participants in the study have a favourable attitude towards hand washing, social distancing, self-quarantine/isolation, and governmental policies regarding COVID-19. Similarly, many people feel anxious about partying, traveling, meetings, online shopping, and social contact. Anxiety related to contracting COVID-19 infection is reported in a larger populace. Most (> 80 percent) of the participants agree with the need for mental healthcare during the COVID-19 pandemic. The Iranian population has a favorable attitude towards the prevention of COVID-19. High anxiety and a perceived need for mental healthcare need in the community necessitates amelioration of mental healthcare during this challenging time.Entities:
Year: 2022 PMID: 35602316 PMCID: PMC9111696 DOI: 10.1111/issj.12332
Source DB: PubMed Journal: Int Soc Sci J ISSN: 0020-8701
Sociodemographic profile of the respondents
|
| ||||
|---|---|---|---|---|
|
|
|
| Mean | SD |
| 1 |
| 350 | 35.6 | 10.72 |
| f | % | |||
| 2 |
| 375 | ||
| Male | 178 | 47.40% | ||
| Female | 196 | 52.10% | ||
| Prefer not to say | 1 | 0.00% | ||
| 3 |
| 372 | ||
| Professional | 114 | 38.70% | ||
| Business | 27 | 7.20% | ||
| Student | 24 | 6.40% | ||
| Other | 122 | 32.70% | ||
| Unemployed | 55 | 14.70% | ||
| Healthcare | 30 | 8.60% | ||
| 4 |
| 375 | ||
| Urban | 355 | 94.60% | ||
| Rural | 20 | 5.30% | ||
| 5 |
| 375 | ||
| Muslim | 375 | 100% | ||
FIGURE 1Distribution of sample population [Colour figure can be viewed at wileyonlinelibrary.com]
Awareness about COVID‐19 in Iranian population (n = 375)*
|
| 5 | 4 | 3 | 2 | 1 | |
|---|---|---|---|---|---|---|
|
|
| Strongly agree | Mostly agree | Somewhat agree | Mostly disagree | Strongly disagree |
| 1 | I can get affected by COVID‐19. | 20 | 58 | 224 | 47 | 22 |
| 2 | I agree to the government guidelines regarding the COVID‐19 pandemic. | 41 | 132 | 99 | 64 | 35 |
| 3 | I think washing hands frequently can lower the risk of COVID‐19. | 169 | 167 | 26 | 5 | 7 |
| 4 | I will be going to quarantine/isolate myself if i have fever and cough. | 165 | 158 | 34 | 10 | 3 |
| 5 | I think social distancing is essential to stop the virus spread. | 248 | 99 | 18 | 7 | 1 |
| 6 | I think traveling across/within the country is safe during these times. | 18 | 20 | 20 | 65 | 250 |
| 7 | Patients with COVID‐19 who are declared cured should not be allowed to stay within the community at this time. | 75 | 0 | 85 | 0 | 215 |
All the items were not answered by all the patients, so the number of responses varied for each item.
FIGURE 2(a) Beliefs on mode of transmission of COVID‐19; (b) Beliefs regarding the nature and outcome of illness (COVID‐19); (c) Perceived mental healthcare need during COVID‐19 pandemic [Colour figure can be viewed at wileyonlinelibrary.com]
Anxiety related to COVID‐19 (n = 375)
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 1 | From the last week, how often do you think about the COVID‐19 pandemic? | 29 | 92 | 88 | 86 | 80 |
| 2 | From the last one week, how often do you feel paranoid about contracting COVID‐19? | 28 | 82 | 100 | 94 | 70 |
| 3 | From the last week, how often you avoid partying? | 20 | 36 | 42 | 97 | 179 |
| 4 | From the last week, how often you avoid social contact? | 18 | 41 | 46 | 144 | 125 |
| 5 | From the last week, how often you avoid large meetings and gatherings? | 13 | 32 | 26 | 85 | 212 |
| 6 | From the last week, how often you avoid ordering food online? | 60 | 8 | 19 | 21 | 267 |
| 7 | From the last week, how often you have talked to your friends about the COVID‐19 pandemic? | 13 | 74 | 97 | 129 | 61 |
| 8 | From the last one week, how often you have had difficulty sleeping by being worried about the COVID‐19 pandemic? | 187 | 78 | 67 | 27 | 15 |
| 9 | From the last week, how often do you feel affected by posts on social media about COVID‐19 infection? | 62 | 103 | 114 | 75 | 20 |
| 10 | From the last week, how often do you feel affected by the talk of the COVID‐19 pandemic on the newspaper and news channels? | 61 | 111 | 105 | 63 | 33 |
| 11 | From the last week, how often do you feel the need to buy and stock all essentials at home? | 20 | 90 | 120 | 95 | 47 |
| 12 | From the last week, how often do you get afraid if anyone in your social circle reports being sick? | 135 | 81 | 92 | 38 | 26 |
| 13 | From the last week, how often do you feel the need to use the sanitiser/gloves? | 14 | 50 | 56 | 93 | 161 |
| 14 | From the last week, how often do feel the need to constantly wash your hands? | 7 | 15 | 34 | 95 | 223 |
| 15 | From the last one week, how often do you feel worried about yourself, and close ones regarding the spread of COVID‐19? | 22 | 72 | 90 | 89 | 101 |
| 16 | From the last week, how often do you use a mask without any apparent signs and symptoms of the infection? | 37 | 47 | 48 | 100 | 142 |
| 17 | From the last week, how often has the idea of COVID‐19 infection freaked (disturbed) you out leading to inappropriate behaviors with anyone? | 134 | 88 | 81 | 32 | 37 |
| 18 | From the last week, how often has the idea of COVID‐19 infection freaked (disturbed) you out due to posts on social media? | 193 | 74 | 64 | 21 | 22 |
Comparison of anxiety related to COVID‐19 in the current study and previous similar study
|
|
|
|
|
|
|---|---|---|---|---|
| 1 | From the last week, how often do you think about the COVID‐19 pandemic? | 166 (44.27%) | 544 (82.2%) | p < 0.0001 |
| 2 | From the last one week, how often you feel paranoid about contracting COVID‐19? | 164 (43.73%) | 250 (37.8%) | p = 0.0647 |
| 3 | From the last week, how often you avoid partying? | 276 (73.60%) | 596 (90.1%) | p < 0.0001 |
| 4 | From the last week, how often you avoid social contact? | 269 (71.73%) | 543 (82.1%) | p = 0.0002 |
| 5 | From the last week, how often you avoid large meetings and gatherings? | 297 (79.2%) | 590 (89.1%) | p < 0.0001 |
| 6 | From the last week, how often you avoid ordering food online? | 288 (76.80%) | 508 (76.7%) | p = 1.0 |
| 7 | From the last week, how often you have talked to your friends about the COVID‐19 pandemic? | 190 (50.67%) | 534 (80.7%) | p < 0.0001 |
| 8 | From the last one week, how often have you had difficulty sleeping due to being worried about the COVID‐19 pandemic? | 42 (11.20%) | 83 (12.5%) | p = 0.5528 |
| 9 | From the last week, how often you feel affected by posts on social media about COVID‐19 infection? | 95 (25.33%) | 241 (36.4%) | p = 0.0002 |
| 10 | From the last week, how often do you feel affected by the talks of the COVID‐19 pandemic in the newspaper and on news channels? | 96 (25.60%) | 305 (46.1%) | p < 0.0001 |
| 11 | From the last week, how often do you feel the need to buy and stock all essentials at home? | 142 (37.87%) | 210 (31.7%) | p = 0.0479 |
| 12 | From the last week, how often do you get afraid if anyone in your social circle reports being sick? | 66 (17.60%) | 273 (41.3%) | p < 0.0001 |
| 13 | From the last week, how often do you feel the need to use the sanitiser/gloves? | 254 (67.73%) | 512 (77.4%) | p = 0.0009 |
| 14 | From the last week, how often do feel the need to constantly wash your hands? | 318 (84.80%) | 559 (84.5%) | p = 0.9288 |
| 15 | From the last one week, how often do you feel worried about yourself, and close ones regarding the spread of COVID‐19? | 190 (50.67%) | 477 (72%) | p < 0.0001 |
| 16 | From the last week, how often do you use a mask without any apparent signs and symptoms of the infection? | 242 (64.53%) | 242 (36.6%) | p < 0.0001 |
| 17 | From the last week, how often does the idea of COVID‐19 infection freak (disturb) you out leading to inappropriate behaviors with anyone? | 69 (18.40%) | 202 (30.5%) | p < 0.0001 |
| 18 | From the last week, how often does the idea of COVID‐19 infection freak (disturb) you out due to posts on social media? | 43 (11.47%) | 296 (44.7%) | p < 0.0001 |
The often and always responses are clubbed together.
STROBE Statement – checklist of items that should be included in reports of observational studies
| Item No | Recommendation | Page | |
|---|---|---|---|
|
| 1 | ( | 1, 2 |
| ( | 2 | ||
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 3 |
| Objectives | 3 | State‐specific objectives, including any prespecified hypotheses | 4 |
| Methods | |||
| Study design | 4 | Present key elements of study design early in the paper | 4 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow‐up, and data collection | 4 |
| Participants | 6 | ( | |
|
| |||
|
(
| |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 4 |
| Data sources/ measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group |
|
| Bias | 9 | Describe any efforts to address potential sources of bias | 4 |
| Study size | 10 | Explain how the study size was arrived at | 4 |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | 4 |
| Statistical methods | 12 | ( | 4 |
| ( | 4 | ||
| ( | 4 | ||
|
(
| 4 | ||
| ( | None | ||
| Results | Page | ||
| Participants | 13* | (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow‐up, and analysed | 5 |
| (b) Give reasons for non‐participation at each stage | 5 | ||
| (c) Consider the use of a flow diagram | |||
| Descriptive data | 14* | (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders | 5 |
| (b) Indicate the number of participants with missing data for each variable of interest | Table | ||
| (c) | |||
| Outcome data | 15* |
| |
|
|
| ||
|
| |||
| Main results | 16 | ( | |
| ( | 5, 6 | ||
| ( | |||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses | |
| Discussion | |||
| Key results | 18 | Summarise key results with reference to study objectives | 7‐9 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 9‐10 |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 10 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 10 |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 1 |
*Give information separately for cases and controls in case‐control studies and, if applicable, for exposed and unexposed groups in cohort and cross‐sectional studies.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe‐statement.org.